Skip to main content

ADVERTISEMENT

Angela Hoye, MB, MRCP, MD, MBChB

08/01/2008
ABSTRACT: The use of bare stents for the percutaneous intervention of saphenous vein bypass grafts (SVGs) is associated with a high subsequent rate of restenosis. To assess the impact of the sirolimus-eluting stent (SES), we studied 19...
ABSTRACT: The use of bare stents for the percutaneous intervention of saphenous vein bypass grafts (SVGs) is associated with a high subsequent rate of restenosis. To assess the impact of the sirolimus-eluting stent (SES), we studied 19...
ABSTRACT: The use of bare stents...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
In this preliminary series, sirolimus-eluting stent implantation appeared safe and effective for the treatment of dialysis patients with coronary artery disease. Dialysis patients are well known to be a high-risk population for cardiovascular...
In this preliminary series, sirolimus-eluting stent implantation appeared safe and effective for the treatment of dialysis patients with coronary artery disease. Dialysis patients are well known to be a high-risk population for cardiovascular...
In this preliminary series,...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Management strategies for ST-elevation myocardial infarction (STEMI) have undergone great evolution over the past decade. Currently, primary mechanical reperfusion is considered superior to thrombolytic therapy in achieving complete and...
Management strategies for ST-elevation myocardial infarction (STEMI) have undergone great evolution over the past decade. Currently, primary mechanical reperfusion is considered superior to thrombolytic therapy in achieving complete and...
Management strategies for...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ostial atherosclerotic lesions constitute a distinct substrate for percutaneous interventions, as they differ from the other lesion sites in management strategies and in clinical outcomes. Since the lesions are more likely fibrotic and...
Ostial atherosclerotic lesions constitute a distinct substrate for percutaneous interventions, as they differ from the other lesion sites in management strategies and in clinical outcomes. Since the lesions are more likely fibrotic and...
Ostial atherosclerotic lesions...
08/01/2008
Journal of Invasive Cardiology
06/19/2008
The major limitation of percutaneous therapy (PCI) for the treatment of chronic total occlusions (CTOs) is the inability to cross with a wire. We report successful recanalization of a CTO situated at the ostium of the left anterior descending...
The major limitation of percutaneous therapy (PCI) for the treatment of chronic total occlusions (CTOs) is the inability to cross with a wire. We report successful recanalization of a CTO situated at the ostium of the left anterior descending...
The major limitation of...
06/19/2008
Cath Lab Digest
Commentary
05/06/2010
Spontaneous coronary artery dissection (SCAD) is a challenge for the interventional cardiologist. Not least because it occurs so rarely that even someone with a large clinical practice will only see a small number of cases, and in addition,...
Spontaneous coronary artery dissection (SCAD) is a challenge for the interventional cardiologist. Not least because it occurs so rarely that even someone with a large clinical practice will only see a small number of cases, and in addition,...
Spontaneous coronary artery...
05/06/2010
Journal of Invasive Cardiology
Feature
06/19/2008
The major limitation of percutaneous therapy (PCI) for the treatment of chronic total occlusions (CTOs) is the inability to cross with a wire. We report successful recanalization of a CTO situated at the ostium of the left anterior descending...
The major limitation of percutaneous therapy (PCI) for the treatment of chronic total occlusions (CTOs) is the inability to cross with a wire. We report successful recanalization of a CTO situated at the ostium of the left anterior descending...
The major limitation of...
06/19/2008
Cath Lab Digest
Case Report
08/01/2008
Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) has procedural and ultimate long-term success rates that are significantly less than those currently reported for nonocclusive lesions. A CTO is generally defined as...
Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) has procedural and ultimate long-term success rates that are significantly less than those currently reported for nonocclusive lesions. A CTO is generally defined as...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
The major limitation of percutaneous therapy (PCI) for the treatment of chronic total occlusions (CTOs) is the inability to cross with a wire. We report successful recanalization of a CTO situated at the ostium of the left anterior descending...
The major limitation of percutaneous therapy (PCI) for the treatment of chronic total occlusions (CTOs) is the inability to cross with a wire. We report successful recanalization of a CTO situated at the ostium of the left anterior descending...
The major limitation of...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
ABSTRACT: Background. Recurrent restenosis following vascular brachytherapy (VBT) has been reported in up to one-third of the patients enrolled in clinical trials. The long-term outcome of repeat percutaneous intervention (PCI) after failed...
ABSTRACT: Background. Recurrent restenosis following vascular brachytherapy (VBT) has been reported in up to one-third of the patients enrolled in clinical trials. The long-term outcome of repeat percutaneous intervention (PCI) after failed...
ABSTRACT: Background. Recurrent...
08/01/2008
Journal of Invasive Cardiology